1-(3-bromophenyl)ethanone Cas:2142-63-4

We are 1-(3-bromophenyl)ethanone CAS:2142-63-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


1-(3-bromophenyl)ethanone

Synonyms:
bromoacetophenone-3
3’-Bromoacetophenone
3'-Bromoacetophenone
1-Acetyl-3-bromobenzene
m-MeOC-C6H4-Br
m-Br-phenylacetophenone
Acetophenone,3'-bromo
Ethanone, 1-(3-bromophenyl)-
3‘-Bromoacetophenone
m-Bromoacetophenone
 
Molecular Formula: C8H7BrO
Molecular weight:199.04500
 
 
Appearance and properties: transparent yellow liquid
Density: 1.505 g/mL at 25 °C(lit.)
Boiling point: 79-81 °C0.2 mm Hg
Melting point: 8-11 °C(lit.)
Flash point: >230 °F
Refractive index: n20/D 1.576(lit.)
 
Stability: Stable at room temperature in closed containers under normal storage and handling conditions.
Storage conditions: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Uses: Used as a raw material for organic synthesis and an intermediate for the synthesis of vascular softening drugs.

 
Items of Analysis Standard of Analysis Test Results
Appearance Light yellow liquid Conform
Assay ≥98.5% 99.51%
3-Nitroacetophenone ≤0.8% 0.26%
Other impurity ≤0.7% 0.23%
Conclusion Conforms to Factory Standard
 




Market News:MSD – known as Merck in the US and Canada – is jointly developing Verquvo with Bayer. While MSD hold the commercial rights to the heart failure med in the US, Bayer has the exclusive commercial rights in the rest of the world. 2-(2-chloro-3-(3-methylisoxazol-5-yl)-4-(methylsulfonyl)benzoyl)-5-(methoxymethyl)-4-methylcyclohexane-1,3-dione manufacturer.Earlier this year, the US Food and Drug Administration approved Verquvo to reduce the risk of cardiovascular death and heart failure hospitalisation, following a hospitalisation for heart failure or need for outpatients intravenous (IV) diuretics in adults with symptomatic chronic heart failure and ejection fraction less than 45%. N-(4-(3-(3-ethoxy-4-methoxyphenyl)-1,4,5,6-tetrahydropyridazine-1-carbonyl)phenyl)-2,2,2-trifluoroacetamide supplier.About eight months after originally teaming up on neuromuscular diseases, Takeda and PeptiDream have expanded the pact to include several central nervous system targets, while revealing the tie-up could be worth more than $3.5 billion. 2-(benzo[c][1,2,5]thiadiazole-4-sulfonamido)-N-(3,4-dichlorophenyl)benzamide producer.

Related Products
Product Name
1,3-Diaminobenzene Sulfate View Details
rac-Des(4-cyclohexyl-L-proline) Fosinopril Acetic Acid View Details
(R,R)-(-)-N,N-Bis(3,5-DI-Tert-Butylsalicylidene)-1,2-Cyclohexanediamine Cas:135616-40-9 View Details
2′,3′,5′-Tri-O-acetyl-D-adenosine manufacturer 2-Cyclohexylmandelic acid manufacturer 4-Chloro-2-fluoroaniline manufacturer tris(8-methylnonyl) benzene-1,2,4-tricarboxylate Cas:36631-30-8 manufacturer N-(2-cyano-4-oxochromen-8-yl)-4-(4-phenylbutoxy)benzamide manufacturer